China has such a dominant position in active pharmaceutical ingredient (API) production that there is a risk it could "weaponise" access, according to a new congressional report. The document, from ...
Google AI Overviews are facing legal and regulatory tests as companies consider how employees use AI search for research, compliance, and high-risk decisions. If you can only read one tech story a day ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results